Intermittent Preventative Treatment With Sulfadoxine-Pyrimethamine in Gambian Multigravidae
A Randomised, Placebo Controlled Trial of Intermittent Preventative Treatment With Sulfadoxine-pyrimethamine in Gambian Multigravidae.
Sponsor: Department of State for Health and Social Welfare, The Gambia
Listed as NCT00120809, this PHASE3 trial focuses on Malaria and remains completed. Sponsored by Department of State for Health and Social Welfare, The Gambia, it has been updated 7 times since 2002, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE3
First recorded
Jul 2002
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Department of State for Health and Social Welfare, The Gambia
- London School of Hygiene and Tropical Medicine
- Medical Research Council Unit, The Gambia
For direct contact, visit the study record on ClinicalTrials.gov .